Literature DB >> 7383883

[Regression under the influence of OP'DDD of a malignant cortico-adrenaloma and of its metastases (author's transl)].

B Charbonnel, J Guillon, M Chupin.   

Abstract

Report of a case of metastatic adrenal cortical carcinoma with Cushing's syndrome treated with OP'DDD, 15 g per day. This therapy was followed by the regression of the adrenal tumour and of its metastases since three years.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7383883

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  2 in total

1.  O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.

Authors:  H von Slooten; A P van Seters; D Smeenk; A J Moolenaar
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Survival rates and prognostic factors in adrenocortical carcinoma.

Authors:  P Icard; A Louvel; Y Chapuis
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.